Diffuse Large B-cell Lymphoma

• CLINICAL_TRIALS research · 2011-10-13
  Clinical Trial Update: Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma [Phase 2]

  A multicenter Phase II pilot trial assessing the efficacy and safety of LR-CHOP21 in elderly patients with untreated diffuse large B-cell ly…

• CLINICAL_TRIALS research · 2011-09-22
  Clinical Trial Update: Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma [Phase 2]

  A Phase 2 clinical trial evaluating rituximab augmentation after R-CHOP induction chemotherapy in extremely elderly patients with diffuse la…

• CLINICAL_TRIALS research · 2011-02-15
  Clinical Trial Update: Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma [Phase 3]

  Phase 3 clinical trial evaluating dose-dense chemotherapy with Rituximab, with or without intensified high-dose chemoimmunotherapy, supporte…

• CLINICAL_TRIALS research · 2010-12-02
  Clinical Trial Update: BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) [Phase 2]

  Phase 2 clinical trial evaluating BuEAM conditioning before autologous stem cell transplantation for diffuse large B-cell lymphoma.

• CLINICAL_TRIALS research · 2010-02-12
  Clinical Trial Update: DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma [Phase 2]

  Clinical trial update for a Phase 2 study of DA-EDOCH14-R in poor-prognosis diffuse large B-cell lymphoma; the current status is unknown.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2010-01-12
  Clinical Trial Update: A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

  A retrospective review of gemcitabine, methylprednisolone, cisplatin (GEM-P) with or without rituximab in relapsed/refractory diffuse large …

• CLINICAL_TRIALS research · 2009-09-21
  Clinical Trial Update: R Retreatment in 1st Relapsed DLBCL [Phase 2]

  This clinical trial update describes a Phase 2 retreatment study using rituximab in patients with first-relapsed diffuse large B-cell lympho…